Predicting 30-day mortality following PEG insertion: External validation of the Sheffield Gastrostomy Score and analysis for additional predictors

and study aims: The Sheffield Gastrostomy Score (SGS) was devised to stratify patients by calculating their risk of mortality at 30 days following PEG insertion. The aim was to externally validate the SGS and identify any further predictors of 30-day mortality. Retrospective review of all PEG insert...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nutrition ESPEN 2021-04, Vol.42, p.227-232
Main Authors: MacLeod, Caitlin S., McKay, Rebecca, Barber, Dorothy, McKinlay, Alastair W., Leeds, John S.
Format: Article
Language:English
Subjects:
Gastrostomy
Indication
Mortality
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-7f9278d3d704b0d299100e21e397f412501abe692e8ea66f18f2bd4241b554c23
cites cdi_FETCH-LOGICAL-c362t-7f9278d3d704b0d299100e21e397f412501abe692e8ea66f18f2bd4241b554c23
container_end_page 232
container_issue
container_start_page 227
container_title Clinical nutrition ESPEN
container_volume 42
creator MacLeod, Caitlin S.
McKay, Rebecca
Barber, Dorothy
McKinlay, Alastair W.
Leeds, John S.
description and study aims: The Sheffield Gastrostomy Score (SGS) was devised to stratify patients by calculating their risk of mortality at 30 days following PEG insertion. The aim was to externally validate the SGS and identify any further predictors of 30-day mortality. Retrospective review of all PEG insertions performed over a ten year period in our centre. All patients who had a new PEG inserted were identified and the SGS calculated. Additionally, demographic, indication for PEG insertion and other blood results were recorded. Receiver operating characteristic curves were calculated and subsequent univariate and multivariate analysis was performed to identify additional risk factors for 30 day mortality. The PEG database comprised 1373 patients, of which 808 were suitable for analysis. For each increasing SGS gradation mortality rose, with 4% of those scoring 0 compared to 50% scoring 3. An area under the ROC curve of 0.69 (95% confidence interval 0.64–0.74) indicated good discriminative capacity. Multivariate analysis demonstrated that age ≥60 years (OR = 2.1 p = 0.016), serum albumin concentrations of 25–34 g/l (OR = 2.5 p = 0.001) or
doi_str_mv 10.1016/j.clnesp.2021.01.032
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2503672676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2405457721000462</els_id><sourcerecordid>2503672676</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-7f9278d3d704b0d299100e21e397f412501abe692e8ea66f18f2bd4241b554c23</originalsourceid><addsrcrecordid>eNp9Ud1qFDEUDqLYUvsGIrn0Zrb5m8mOF4KUdSsULFSvQyY5sVkykzXJVuc1fGIzTBWvhBMSku8n53wIvaZkQwntrg4bEybIxw0jjG5ILc6eoXMmSNuIVsrn_5zP0GXOB0Iqr-8FJS_RGedStO1WnKNfdwmsN8VP3zAnjdUzHmMqOvgyYxdDiD-Wp7vdHvspQyo-Tu_w7meBNOmAHyvQ6uUSR4fLA-D7B3DOQ7B4r3NJMZc4zvjexARYT7YuHebscxVPWFvrF3JVOq7_iCm_Qi-cDhkun_YL9PXj7sv1TXP7ef_p-sNtY3jHSiNdz-TWciuJGIhlfU8JAUaB99IJylpC9QBdz2ALuusc3To2WMEEHdpWGMYv0NtV95ji9xPkokafDYSgJ4inrKoC7yTrZFehYoWa2lBO4NQx-VGnWVGilkDUQa2BqCUQRWrxxeHNk8NpGMH-Jf0ZfwW8XwFQ-3z0kFQ2HiZTR5HAFGWj_7_Db81Yn-Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2503672676</pqid></control><display><type>article</type><title>Predicting 30-day mortality following PEG insertion: External validation of the Sheffield Gastrostomy Score and analysis for additional predictors</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>MacLeod, Caitlin S. ; McKay, Rebecca ; Barber, Dorothy ; McKinlay, Alastair W. ; Leeds, John S.</creator><creatorcontrib>MacLeod, Caitlin S. ; McKay, Rebecca ; Barber, Dorothy ; McKinlay, Alastair W. ; Leeds, John S.</creatorcontrib><description>and study aims: The Sheffield Gastrostomy Score (SGS) was devised to stratify patients by calculating their risk of mortality at 30 days following PEG insertion. The aim was to externally validate the SGS and identify any further predictors of 30-day mortality. Retrospective review of all PEG insertions performed over a ten year period in our centre. All patients who had a new PEG inserted were identified and the SGS calculated. Additionally, demographic, indication for PEG insertion and other blood results were recorded. Receiver operating characteristic curves were calculated and subsequent univariate and multivariate analysis was performed to identify additional risk factors for 30 day mortality. The PEG database comprised 1373 patients, of which 808 were suitable for analysis. For each increasing SGS gradation mortality rose, with 4% of those scoring 0 compared to 50% scoring 3. An area under the ROC curve of 0.69 (95% confidence interval 0.64–0.74) indicated good discriminative capacity. Multivariate analysis demonstrated that age ≥60 years (OR = 2.1 p = 0.016), serum albumin concentrations of 25–34 g/l (OR = 2.5 p = 0.001) or &lt;25 g/l (OR = 6.8 p &lt; 0.001), C-Reactive Protein ≥10 mg/l (OR = 2.7 p = 0.009) and lymphocyte count of &lt;1.5 × 109/l (OR = 2.0 p = 0.004) increased the odds of 30-day mortality, whilst referral for PEG placement whilst an inpatient decreased the risk of death (OR = 0.53 p = 0.005). The SGS displayed reasonable predictive ability but the area under the curve is not high enough for routine clinical use. Modelling of further predictors from a multicentre study could provide scope for updating the SGS potentially improving patient selection.</description><identifier>ISSN: 2405-4577</identifier><identifier>EISSN: 2405-4577</identifier><identifier>DOI: 10.1016/j.clnesp.2021.01.032</identifier><identifier>PMID: 33745584</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Gastrostomy ; Indication ; Mortality</subject><ispartof>Clinical nutrition ESPEN, 2021-04, Vol.42, p.227-232</ispartof><rights>2021 European Society for Clinical Nutrition and Metabolism</rights><rights>Copyright © 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-7f9278d3d704b0d299100e21e397f412501abe692e8ea66f18f2bd4241b554c23</citedby><cites>FETCH-LOGICAL-c362t-7f9278d3d704b0d299100e21e397f412501abe692e8ea66f18f2bd4241b554c23</cites><orcidid>0000-0002-9058-2942 ; 0000-0002-5900-3105 ; 0000-0002-5140-6225</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33745584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MacLeod, Caitlin S.</creatorcontrib><creatorcontrib>McKay, Rebecca</creatorcontrib><creatorcontrib>Barber, Dorothy</creatorcontrib><creatorcontrib>McKinlay, Alastair W.</creatorcontrib><creatorcontrib>Leeds, John S.</creatorcontrib><title>Predicting 30-day mortality following PEG insertion: External validation of the Sheffield Gastrostomy Score and analysis for additional predictors</title><title>Clinical nutrition ESPEN</title><addtitle>Clin Nutr ESPEN</addtitle><description>and study aims: The Sheffield Gastrostomy Score (SGS) was devised to stratify patients by calculating their risk of mortality at 30 days following PEG insertion. The aim was to externally validate the SGS and identify any further predictors of 30-day mortality. Retrospective review of all PEG insertions performed over a ten year period in our centre. All patients who had a new PEG inserted were identified and the SGS calculated. Additionally, demographic, indication for PEG insertion and other blood results were recorded. Receiver operating characteristic curves were calculated and subsequent univariate and multivariate analysis was performed to identify additional risk factors for 30 day mortality. The PEG database comprised 1373 patients, of which 808 were suitable for analysis. For each increasing SGS gradation mortality rose, with 4% of those scoring 0 compared to 50% scoring 3. An area under the ROC curve of 0.69 (95% confidence interval 0.64–0.74) indicated good discriminative capacity. Multivariate analysis demonstrated that age ≥60 years (OR = 2.1 p = 0.016), serum albumin concentrations of 25–34 g/l (OR = 2.5 p = 0.001) or &lt;25 g/l (OR = 6.8 p &lt; 0.001), C-Reactive Protein ≥10 mg/l (OR = 2.7 p = 0.009) and lymphocyte count of &lt;1.5 × 109/l (OR = 2.0 p = 0.004) increased the odds of 30-day mortality, whilst referral for PEG placement whilst an inpatient decreased the risk of death (OR = 0.53 p = 0.005). The SGS displayed reasonable predictive ability but the area under the curve is not high enough for routine clinical use. Modelling of further predictors from a multicentre study could provide scope for updating the SGS potentially improving patient selection.</description><subject>Gastrostomy</subject><subject>Indication</subject><subject>Mortality</subject><issn>2405-4577</issn><issn>2405-4577</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9Ud1qFDEUDqLYUvsGIrn0Zrb5m8mOF4KUdSsULFSvQyY5sVkykzXJVuc1fGIzTBWvhBMSku8n53wIvaZkQwntrg4bEybIxw0jjG5ILc6eoXMmSNuIVsrn_5zP0GXOB0Iqr-8FJS_RGedStO1WnKNfdwmsN8VP3zAnjdUzHmMqOvgyYxdDiD-Wp7vdHvspQyo-Tu_w7meBNOmAHyvQ6uUSR4fLA-D7B3DOQ7B4r3NJMZc4zvjexARYT7YuHebscxVPWFvrF3JVOq7_iCm_Qi-cDhkun_YL9PXj7sv1TXP7ef_p-sNtY3jHSiNdz-TWciuJGIhlfU8JAUaB99IJylpC9QBdz2ALuusc3To2WMEEHdpWGMYv0NtV95ji9xPkokafDYSgJ4inrKoC7yTrZFehYoWa2lBO4NQx-VGnWVGilkDUQa2BqCUQRWrxxeHNk8NpGMH-Jf0ZfwW8XwFQ-3z0kFQ2HiZTR5HAFGWj_7_Db81Yn-Y</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>MacLeod, Caitlin S.</creator><creator>McKay, Rebecca</creator><creator>Barber, Dorothy</creator><creator>McKinlay, Alastair W.</creator><creator>Leeds, John S.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9058-2942</orcidid><orcidid>https://orcid.org/0000-0002-5900-3105</orcidid><orcidid>https://orcid.org/0000-0002-5140-6225</orcidid></search><sort><creationdate>202104</creationdate><title>Predicting 30-day mortality following PEG insertion: External validation of the Sheffield Gastrostomy Score and analysis for additional predictors</title><author>MacLeod, Caitlin S. ; McKay, Rebecca ; Barber, Dorothy ; McKinlay, Alastair W. ; Leeds, John S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-7f9278d3d704b0d299100e21e397f412501abe692e8ea66f18f2bd4241b554c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Gastrostomy</topic><topic>Indication</topic><topic>Mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MacLeod, Caitlin S.</creatorcontrib><creatorcontrib>McKay, Rebecca</creatorcontrib><creatorcontrib>Barber, Dorothy</creatorcontrib><creatorcontrib>McKinlay, Alastair W.</creatorcontrib><creatorcontrib>Leeds, John S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nutrition ESPEN</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MacLeod, Caitlin S.</au><au>McKay, Rebecca</au><au>Barber, Dorothy</au><au>McKinlay, Alastair W.</au><au>Leeds, John S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predicting 30-day mortality following PEG insertion: External validation of the Sheffield Gastrostomy Score and analysis for additional predictors</atitle><jtitle>Clinical nutrition ESPEN</jtitle><addtitle>Clin Nutr ESPEN</addtitle><date>2021-04</date><risdate>2021</risdate><volume>42</volume><spage>227</spage><epage>232</epage><pages>227-232</pages><issn>2405-4577</issn><eissn>2405-4577</eissn><abstract>and study aims: The Sheffield Gastrostomy Score (SGS) was devised to stratify patients by calculating their risk of mortality at 30 days following PEG insertion. The aim was to externally validate the SGS and identify any further predictors of 30-day mortality. Retrospective review of all PEG insertions performed over a ten year period in our centre. All patients who had a new PEG inserted were identified and the SGS calculated. Additionally, demographic, indication for PEG insertion and other blood results were recorded. Receiver operating characteristic curves were calculated and subsequent univariate and multivariate analysis was performed to identify additional risk factors for 30 day mortality. The PEG database comprised 1373 patients, of which 808 were suitable for analysis. For each increasing SGS gradation mortality rose, with 4% of those scoring 0 compared to 50% scoring 3. An area under the ROC curve of 0.69 (95% confidence interval 0.64–0.74) indicated good discriminative capacity. Multivariate analysis demonstrated that age ≥60 years (OR = 2.1 p = 0.016), serum albumin concentrations of 25–34 g/l (OR = 2.5 p = 0.001) or &lt;25 g/l (OR = 6.8 p &lt; 0.001), C-Reactive Protein ≥10 mg/l (OR = 2.7 p = 0.009) and lymphocyte count of &lt;1.5 × 109/l (OR = 2.0 p = 0.004) increased the odds of 30-day mortality, whilst referral for PEG placement whilst an inpatient decreased the risk of death (OR = 0.53 p = 0.005). The SGS displayed reasonable predictive ability but the area under the curve is not high enough for routine clinical use. Modelling of further predictors from a multicentre study could provide scope for updating the SGS potentially improving patient selection.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33745584</pmid><doi>10.1016/j.clnesp.2021.01.032</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-9058-2942</orcidid><orcidid>https://orcid.org/0000-0002-5900-3105</orcidid><orcidid>https://orcid.org/0000-0002-5140-6225</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2405-4577
ispartof Clinical nutrition ESPEN, 2021-04, Vol.42, p.227-232
issn 2405-4577
2405-4577
language eng
recordid cdi_proquest_miscellaneous_2503672676
source ScienceDirect Freedom Collection 2022-2024
subjects Gastrostomy
Indication
Mortality
title Predicting 30-day mortality following PEG insertion: External validation of the Sheffield Gastrostomy Score and analysis for additional predictors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T09%3A16%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predicting%2030-day%20mortality%20following%20PEG%20insertion:%20External%20validation%20of%20the%20Sheffield%20Gastrostomy%20Score%20and%20analysis%20for%20additional%20predictors&rft.jtitle=Clinical%20nutrition%20ESPEN&rft.au=MacLeod,%20Caitlin%20S.&rft.date=2021-04&rft.volume=42&rft.spage=227&rft.epage=232&rft.pages=227-232&rft.issn=2405-4577&rft.eissn=2405-4577&rft_id=info:doi/10.1016/j.clnesp.2021.01.032&rft_dat=%3Cproquest_cross%3E2503672676%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-7f9278d3d704b0d299100e21e397f412501abe692e8ea66f18f2bd4241b554c23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2503672676&rft_id=info:pmid/33745584&rfr_iscdi=true